Skip to main content
. 2023 Aug 22;16(9):1191. doi: 10.3390/ph16091191

Table 2.

Summary of BIM compounds solved as ligands in kinase crystal structures [74,81,82,83,84,85,86,87,88,89,90,91,92,93,94].

BIM-Type Ligand Kinase Family PDB Reference
BIM-I PDK1 AGC 1UU8 [74]
PIM1 CAMK 1XWS [81]
PIM1 CAMK 2BIK [82]
PIM1 CAMK 2BIL [83]
PKC-1 AGC 1ZRZ [84]
BIM-II PDK1 AGC 1UU7 [74]
PDK1 AGC 3ORZ [85]
PDK1 AGC 3OTU [85]
BIM-III PDK1 AGC 1UU9 [74]
BIM-VII DMPK1 AGC 2VD5 [86]
BIM-VIII PDK1 AGC 1UVR [74]
Ruboxistaurin 61 PDK1 AGC 1UU3 [74]
PIM1 CAMK 2J2I [87]
BfIM 71 GSK-3β CMGC 3SD0 [88]
graphic file with name pharmaceuticals-16-01191-i001.jpg PKC-β AGC 2I0E [89]
graphic file with name pharmaceuticals-16-01191-i002.jpg GSK-3β CMGC 2OW3 [90]
Indolyl phenyl maleimide 94 GSK-3β CMGC 1R0E [91]
Indolyl pyrimidinyl maleimide 95 JAK3 TK 3PJC [92]
Indolyl pyrroloquinolinyl maleimide 96 MET TK 3RHK [93]
Indolyl quinazolinyl maleimide 97 PKC-α AGC 3IW4 [94]